Established in Chicago, Illinois, Goldfinch invests in private equity and venture capital funds and directly owns and operates businesses alongside our world-class network of experienced investors, operators, and board members.
We apply family business principles to everything we do. We’ve been family from our genesis and have no intention of deviating. Our sophistication, people, processes, and technology are on par with the top players in the financial market, and our competitive edge is that we can see the entire market at a birds-eye view.
At Goldfinch, our leadership team combines decades of experience across public markets, private equity, and business ownership. Each member brings a unique perspective and proven track record, united by a shared commitment to applying family principles to build enduring partnerships and achieve exceptional results. Meet the visionaries shaping our strategy and driving our success.
Founder and Chief Executive Officer
Omair Ahmed is a Founder and Chief Executive Officer of Goldfinch.
Prior to founding Goldfinch, Omair served as Chief Operating Officer and member of the Board of Directors at Nexus Pharmaceuticals, Inc. After joining Nexus in 2011 as Director of Trade Relations, he quickly advanced to positions of increasing responsibility within the commercial business. During his tenure, he was responsible for growth strategy and strategic partnerships to continue to expand Nexus’ global reach and impact. Under his leadership, Nexus successfully divested its state-of-the-art pharmaceutical manufacturing facility in 2024.
Prior to Nexus, Omair worked in field sales at Beckman Coulter. He currently sits on the Board of Directors of the University of Wisconsin – Parkside Foundation.
Omair holds a Bachelor of Economics degree from the University of Illinois Urbana-Champaign.
Principal Investor
Prior to founding Goldfinch, Usman served as Chief Executive Officer and member of the Board of Directors at Nexus Pharmaceuticals, LLC.
After joining Nexus in 2009 as VP of Finance and Business Development, he was first promoted to the Chief Financial Officer and then the Chief Executive Offices role as he continuously set and achieved strategic goals for the business. Usman executed complex transactions, drove quality improvement, and expense reduction in the difficult-to-manufacture specialty and generic injectable drug space.
Recognized for his ability to build high-achieving teams under constant organizational change. Under his leadership, Nexus successfully divested its state-of-the-art pharmaceutical manufacturing facility in 2024. Prior to Nexus, Usman worked as an Associate at J.P. Morgan. Usman holds a Bachelor of Finance degree from The Ohio State University.
Principal Investor
Prior to Goldfinch, Aman began his career at Nexus Pharmaceuticals, LLC in 2017, where he currently serves on the Board of Directors. As the Director of International Sales, he oversees the International Business Development, managing the company’s portfolio of products across multiple global regions.
With over seven years of experience, Aman has developed expertise in sales operations, navigating DEA and FDA regulations, inside sales, and portfolio management across various therapeutic lines. At Nexus, he was paramount in the strategic expansion of the Pleasant Prairie manufacturing facility and subsequent divestiture to Eli Lilly.
His investment interests span healthcare, sustainability, and entertainment. Aman holds a Bachelor of Science degree in Healthcare Management and Policy from Indiana University.
Chief Investment Officer
Alex was Goldfinch’s first employee, joining as Chief Investment Officer and head of the public equity, IPO, options and derivatives fund “Mamba Equities”, the private equity and venture capital fund “Mustang Investments” and the direct investment platform “The Sand Tiger Companies”.
Alex is a trained investment banker and private equity professional, having spent time advising and investing in industrials, healthcare, consumer, financial services, technology, and defense at Evercore Partners, Madison Dearborn Partners and BDT&MSD. In these roles he has been involved in managing investments in Weber Grill, Panera Bread, Einstein Bagels, Caribou Coffee, Pret-a-Manger, Espresso House, SIRVA BGRS, Kaufman Hall & Associates and Benefytt Technologies. Alex most recently stepped into operations at Nexus Pharmaceuticals as Executive Vice President of Operations, assisting in competitor litigation settlements, government relations and leading several divisions including sales and forecasting, project management and analytics.
He currently Chairs the investment committee of Goldfinch, Chairs the LPAC of a technology venture capital fund, serves on three corporate company boards directly and one non-profit Catholic board. Alex is a proud alumnus of the University of Notre Dame.
Chief Financial Officer
As Chief Financial Officer, Evan is responsible for the day-to-day operations of Goldfinch including financial reporting, tax, treasury, compliance, and investment committee functions.
Prior to joining Goldfinch, Evan served as a Principal for a single-family office where he spent seven years scaling the office’s operations and build-out of a direct investing platform. He navigated the family through wealth events, leading to headcount expansion, systems implementations, and proactive estate planning. Through that experience, he oversaw all asset management, served on boards of middle-market companies, invested in and advised start-ups, bought and sold real estate assets, and sat on numerous investment committees.
Prior, he operated a multi-generation family office and worked in fund administration. Evan holds a Bachelor of Finance degree from Drake University, Master of Business Administration from DePaul University, and is a Certified Public Accountant.
Goldfinch operates a fleet of vehicles, each one with a different purpose, strengthening the others daily.
Invests in the public market directly, trade single-stocks, options, derivatives, participate in IPOs, tax loss harvest, write our own thought leadership pieces, and communicate with the largest hedge funds and investment banks in the world daily
Invests in incubators, venture capitalists, growth equity firms, lower-middle market, middle-market, and mega-fund private equity, open-ended evergreen vehicles, and fund of funds
Provide capital to family-owned businesses alongside founders and own/operate our own portfolio companies – all alongside our network and honoring our family-first mindset
We are closed to outside capital at this time. If you or someone you know is interested in partnering with Goldfinch, please fill out our contact form.